Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 175.71% vs 27.93% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -2.56% vs -36.25% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 11.78% vs 7.15% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -178.29% vs 69.93% in Mar 2024
Compare Profit and Loss Results of Oxygenta Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
109.00
1,908.00
-1,799.00
-94.29%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
238.00
-238.00
-100.00%
Net Sales
109.00
1,669.00
-1,560.00
-93.47%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
117.00
-120.00
-102.56%
Raw Materials Consumed
100.00
1,250.00
-1,150.00
-92.00%
Power & Fuel Cost
6.00
103.00
-97.00
-94.17%
Employee Cost
6.00
96.00
-90.00
-93.75%
Operating Expenses
5.00
59.00
-54.00
-91.53%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
46.00
-46.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
3.00
-3.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
119.00
1,699.00
-1,580.00
-93.00%
Operating Profit (PBDIT) excl Other Income
-9.00
-29.00
20.00
68.97%
Other Income
1.00
4.00
-3.00
-75.00%
Operating Profit (PBDIT)
-8.00
-24.00
16.00
66.67%
Interest
1.00
74.00
-73.00
-98.65%
Profit before Depriciation and Tax
-10.00
-99.00
89.00
89.90%
Depreciation
0.00
62.00
-62.00
-100.00%
Profit Before Taxation & Exceptional Items
-11.00
-161.00
150.00
93.17%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-11.00
-161.00
150.00
93.17%
Provision for Tax
-1.00
-47.00
46.00
97.87%
Profit After Tax
-9.00
-113.00
104.00
92.04%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-63.00
703.00
-766.00
-108.96%
Profit Available for appropriations
-73.00
590.00
-663.00
-112.37%
Appropriations
-73.00
590.00
-663.00
-112.37%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-2.69
-5.07
2.38
46.94%
Profit And Loss - Net Sales
Net Sales 109.30 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 175.71% vs 27.93% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -9.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.56% vs -36.25% in Mar 2024
Profit And Loss - Interest
Interest 1.78 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.78% vs 7.15% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax -9.68 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -178.29% vs 69.93% in Mar 2024
